Targeting postprandial blood sugar over fasting blood sugar: A clinic based comparative study

Show simple item record

dc.contributor.author Herath, H. M. M.
dc.contributor.author Weerarathna, T. P.
dc.contributor.author Fonseka, C. L.
dc.contributor.author Vidanagamage, A. S.
dc.date.accessioned 2023-07-25T07:45:07Z
dc.date.available 2023-07-25T07:45:07Z
dc.date.issued 2016
dc.identifier.citation Herath HMM, Weerarathna TP, Fonseka CL, Vidanagamage AS. Targeting postprandial blood sugar over fasting blood sugar: A clinic based comparative study. Diabetes Metab Syndr. 2017 Apr-Jun;11(2):133-136. doi: 10.1016/j.dsx.2016.06.029. Epub 2016 Oct 5. PMID: 27746068. en_US
dc.identifier.uri http://ir.lib.ruh.ac.lk/xmlui/handle/iruor/13823
dc.description.abstract Introduction: Recent studies indicate that modulation of post prandial blood sugar (PPBS) plays an important role in the long term glycemic control. Measurement of PPBS is more convenient for patients attending outpatient clinics than fasting blood sugar (FBS) as the former needs only two hours of fasting from the last meal. Objective: To assess the value of PPBS monitoring in optimization of long term glycemic control among diabetic patients attending an outpatient clinic. Methods: A total of 240 patients with type 2 diabetes (T2DM) attending an out-patient medical clinic were randomized to either PPBS or FBS monitoring. Those who selected to PPBS-group underwent blood sugar measurement 2-h after last meal on the day of their clinic visits and those in the FBS group underwent blood sugar measurement after fasting overnight (8-10h) in the morning of their clinic visits. Treating team was asked to optimize the anti-diabetic medications based on the available PPBS or FBS results. All patients were followed up monthly for six months. Glycemic control was assessed with glycosylated hemoglobin (HbA1c) at baseline and six months later. Results: Baseline characteristics of the two arms including age, gender, and duration of T2DM were not significantly different. Mean HbA1c (SD) of FBS and PPBS arms at baseline were 7.20 (0.45), and 7.33 (0.43) and were not significantly different (P=0.115). During the study period, HbA1c dropped by 0.20 in FBS arm compared to 0.25 drop in PPBS arm (p=0.59). Incidence of hypoglycemia was similar in FBS (2.42%) and PPBS arms (2.70%). Conclusion: Monitoring of PPBS is a safe and effective alternative to FBS to optimize glycemic control in managing patients with T2DM attending outpatient clinics. en_US
dc.language.iso en en_US
dc.publisher Elsevier en_US
dc.subject Glycemic control en_US
dc.subject Glycosylated hemoglobin en_US
dc.subject Outpatient management en_US
dc.subject Sole marker en_US
dc.title Targeting postprandial blood sugar over fasting blood sugar: A clinic based comparative study en_US
dc.type Article en_US


Files in this item

This item appears in the following Collection(s)

Show simple item record

Search DSpace


Browse

My Account